- 09 May `25ICP-332 tablets for nonsegmental vitiligoRecruiting nowBeijing InnoCare Pharma Tech Co., Ltd. plans to enroll about 603 participants. The study drug is an experimental oral or topical immune-modulating medicine designed to reduce inflammatory signaling. Researchers hope it will slow melanocyte damage ...
Location: 45 listed sites: China (45) - 01 Apr `25Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCTRecruiting nowThis clinical study aims to compare the safety and effectiveness of two treatments-oral Tacrolimus capsules and Dexamethasone micro-pulse therapy-in children aged 4-12 years with rapidly progressing vitiligo. The study is a multicenter, randomized...
Location: Xijing Hospital, Xi'an, Shaanxi, 710032, China - 25 Mar `25FB102 antibody treatment for nonsegmental vitiligoRecruiting nowForte Biosciences, Inc. plans to enroll about 64 participants. FB102 is an experimental antibody that targets CD122 and changes IL-2 and IL-15 immune signaling. It is intended to reduce disease-driving T-cell activity so melanocytes can recover an...
Location: 6 listed sites: Australia (3); New Zealand (3) - 01 Mar `25Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo PatientsRecruiting nowThis randomized controlled trial aims to compare the efficacy of needling versus microneedling, both followed by narrowband UVB therapy, in achieving repigmentation in patients with localized stable non-segmental vitiligo.Phase: Phase 4.What is be...
Location: Khyber Teaching Hospital, Peshawar, Khyber Pakhtunkhwa, 25000, Pakistan - 01 Feb `25Fondazione Policlinico Universitario Agostino Gemelli IRCCS plans to enroll about 400 participants. This is an observational study, so researchers will not assign an experimental treatment. Researchers are studying public attitudes and stigma towa...
Location: Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Dermatologia, Roma, Italia, Italy (Recruiting) - 04 Dec `24Upadacitinib after pigment-cell transplant for vitiligoRecruiting nowJilin University plans to enroll about 60 participants. Upadacitinib is an oral JAK inhibitor that reduces inflammatory immune signaling. Researchers hope it will slow melanocyte destruction and improve repigmentation, alone or after cell transpla...
Location: Department of Dermatology and Venerology, The First Hospital of Jilin University, No. 1 Xinmin Street, Changchun, Jilin, China (Recruiting) - 29 Nov `24Topical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to Topical TacrolimusRecruiting nowThis trial is a prospective, open-label, single-center, split face randomized controlled study comparing 1.5% topical Ruxolitinib cream twice daily (BD) to aqueous cream in treating non-segmental vitiligo (NSV) of the face and neck in patient prev...
Location: Queen Mary Hospital, Hospital Authority, Hong Kong, Hong Kong - 02 Oct `24Vitiligo, New Treatment and Serum s100BRecruiting nowvitiligo is an autoimmune depigmenting skin disorder characterized by milky white macules or patches, with 2% worldwide prevalence. Vitiligo has unexpected course that significantly influences on patient's quality of life and self-esteem. Multiple...
Location: Qena university hospital, Qena faculty of medicine, Qina, Egypt - 25 Apr `24Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of VitiligoRecruiting nowTo observe the long-term efficacy and safety of autologous non cultured epidermal cell suspension transplantation in the treatment of vitiligo, analyze the correlation between cell density, type, and postoperative efficacy and prognosis, and provi...
Location: Peking University People's Hospital, Beijing, Beijing Municipality, 100044, China - 15 Oct `22Topical fluorouracil for stable vitiligoRecruiting nowAl-Azhar University plans to enroll about 60 participants. Fluorouracil is applied after needling or laser treatment to encourage pigment cells to move into pale skin. Researchers hope the combination will improve repigmentation in stable vitiligo...
Location: Facualty of Pharmacy, Al Azhar University, Cairo, Egypt (Recruiting) - 30 May `21Investigators plan to perform a pilot study that aims to characterize the microbiome of human vitiligo patients with both active and stable disease and compare this to the microbiome of age and sex matched controls. The investigators aim to answer...
Location: Northwestern University, Chicago, Illinois, 60611, United States - 30 Sep `26This study is a multicenter, open-label, non-randomized study designed to evaluate the pharmacokinetics (PK), safety, and preliminary efficacy of VC005 tablets in adolescent subjects with Non-Segmental VitiligoPhases: Phase 1, Phase 2.What is bein...
Location: The Peking University People's Hospital, Beijing, Beijing Municipality, China - 30 Sep `26This randomized controlled prospective single-blinded comparative clinical study aims to compare the efficacy and safety of fractional carbon dioxide (CO2) laser therapy versus mechanical dermabrasion, both combined with topical 5-fluorouracil, in...
Location: Faculty of medicine, Al-Azhar University Assuit, Asyut, Asyut Governorate, 71511, Egypt - 30 Sep `26This is a multicenter, randomized, double-blind, placebo-controlled, adaptive seamless design, Phase II/III study evaluating the efficacy and safety of FXS5626 in participants with non-segmental vitiligo.Phases: Phase 2, Phase 3.What is being stud...
Location: Huashan Hospital, Fudan University, Shanghai, Shanghai Municipality, 200040, China - 01 Sep `26Vitiligo affects approximately 1 to 2% of the global population and significantly impacts people's quality of life. Achieving the best treatment outcomes for vitiligo involves addressing the autoimmune inflammatory response for stopping the depigm...
Location: CHU de Nice, Nice, Alpes-maritimes, 06200, France - 01 Aug `26TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual c...
Location: Greenwich Village Dermatology, New York, New York, 10012, United States - 01 Jul `26NCMT Technique and Jodhpur Technique and Excimer Laser in Treatment of Non Vitiligo LeucodermaOpening soonThis study aims to compare the efficacy and safety of Melanocyte Keratinocyte Transplantation Procedure (MKTP) combined with 308-nm excimer laser versus Jodhpur technique combined with 308-nm excimer laser in the treatment of stable non-vitiligo l...
- 01 Jun `26This study aims to compare the efficacy and safety of PUVA versus Tofacitinib in the treatment of generalized vitiligo. Given the high prevalence of vitiligo in Pakistan and the significant psychosocial impact on patients, particularly in Peshawar...
Location: MTI-HMC Peshawar, Peshawar, Khyber Pukhtunkhwa, 25000, Pakistan - 01 Jun `26A Study to Learn How Safe ACT-777991 is and How Well it Works in Adults With Non-segmental VitiligoOpening soonThe purpose of this clinical trial is to learn how well ACT-777991 works, how safe it is and how well it is tolerated by adults with non-segmental vitiligo. The main question this clinical trial aims to answer is: • Can ACT-777991 help return colo...
Location: No study locations reported - 01 Jun `26This is a randomized, double-blind, placebo-controlled Phase Ib/II clinical trial of multiple subcutaneous injections of GR2301 in combination with phototherapy to evaluate the tolerability, safety, pharmacokinetics, and preliminary efficacy in tr...
Location: No study locations reported - 01 Jun `26Ruxolitinib cream for children ages 2 to 11Opening soonThe Children's Hospital of Zhejiang University School of Medicine plans to enroll about 20 participants. Ruxolitinib cream blocks JAK1 and JAK2 signals that help sustain the immune attack on pigment-producing cells. It is intended to calm inflamma...
Location: Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China - 31 May `26Evaluation of the Efficacy and Safety of LW402 Tablets in Patients With Non-Segmental VitiligoOpening soonThis is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial designed to assess the efficacy, safety, and tolerability of LW402 tablets in participants with non-segmental vitiligo. Drawing on the prior/preclinical da...
Location: No study locations reported - 20 May `26Comparative Study of Microneedling With Topical Minoxidil 5% ± NB-UVB in Stable Vitiligo"Opening soonThis study is a randomized controlled trial comparing microneedling with topical minoxidil 5% versus microneedling with minoxidil combined with NB-UVB phototherapy in stable vitiligo. It aims to evaluate both clinical and histopathological outcome...
Location: No study locations reported - 15 May `26Vitiligo is the most common depigmentation disorder affecting around 1% of the population worldwide. Fifty two percent of patients develop vitiligo before the age of 20 and around 80% develop vitiligo before the age of 30 years old.1 Vitiligo ofte...
Location: The Royal Wolverhampton NHS Trust, Wolverhampton, WV10 0QP, United Kingdom - 01 May `26Assiut University plans to enroll about 50 participants. The procedure makes controlled tiny injuries in the skin, sometimes to improve delivery of a medicine or add targeted UVB light. This may stimulate healing and help pigment cells move into o...
Location: No study locations reported
Seeking a Clinical Trial in Vitiligo
Clinical trials help researchers learn whether new ways to diagnose, manage, or treat vitiligo are safe and effective. They may test a medicine, light therapy, a procedure, or a combination of treatments. Some studies simply follow people over time — no experimental treatment involved.
VRF lists studies from public registries. We do not screen or recommend joining. Some sponsors contract with us for study-awareness support; those placements are disclosed when they go live. Status and sites change. Confirm them on the official record and with the research site.
If this is unfamiliar territory, start with the FAQ.
Find vitiligo studies nearby
Vitiligo Studies Recruiting Now
70 trials in total
FAQOther Questions
- How can I explain vitiligo to my children?
Vitiligo can be confusing for children because it doesn’t resemble an "illness" in the typical sense. Choosing the right way to explain it depends on your child’s age and maturi...
- What's the status with official recognition of World Vitiligo Day?
In 2016, the United Nations marked World Vitiligo Day in its International Calendar of Disability Events. However, it was removed in 2019 when the calendar was streamlined to 'M...
- What are the best predictors for therapy response in vitiligo?
A fair question. Also a slightly annoying one, because dermatology loves nuance and patients usually want something more like a weather forecast. Still, a few factors do show up...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.